Stabilized β-catenin immortalizes colonic epithelial cells

Cancer Research

Volumn 61, Issue 5, 2001, Pages 2097-2104

  Wagenaar, R A ^a   Crawford, H C ^a   Matrisian, L M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; BETA GALACTOSIDASE; T LYMPHOCYTE ANTIGEN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL IMMORTALIZATION; CELL TRANSFORMATION; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE; PRIORITY JOURNAL; PROTEIN STABILITY; TEMPERATURE SENSITIVITY;

ANIMALS; APOPTOSIS; BETA CATENIN; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; COLON; CYTOSKELETAL PROTEINS; EPITHELIAL CELLS; FEMALE; INTESTINAL MUCOSA; MICE; MICE, NUDE; PROTEIN BIOSYNTHESIS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035266351     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Differential nuclear translocation and transactivation potential of β-catenin and plakoglobin
2. The role of β-catenin in cell adhesion, signal transduction, and cancer
3. β-Catenin: A key mediator of Wnt signaling
4. Vinculin is associated with the E-cadherin adhesion complex
5. Wnt signaling: A common theme in animal development
6. β-Catenin is a target for the ubiquitin-proteasome pathway
7. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly
8. Axin a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin
9. Wnt-induced dephosphorylation of axin releases β-catenin from the axin complex
10. Functional interaction of β-catenin with the transcription factor LEF-1
11. Nuclear localization of β-catenin by interaction with transcription factor LEF-1
12. -/- colon carcinoma
13. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
14. Identification of c-MYC as a target of the APC pathway
15. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
16. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors
17. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs
18. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
19. WISP-I is a Wnt-1- and β-catenin-responsive oncogene
20. Gastrin is a target of the β-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis
21. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene
22. Identification and characterization of the familial adenomatous polyposis coli gene
23. Identification of a gene located at chromosome5q21 that is mutated in colorectal cancers
24. Mutations of chromosome5q21 genes in FAP and colorectal cancer patients
25. Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP)
26. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP)
27. Inactivation of both APC alleles in human and mouse tumors
28. Suppression of intestinal neoplasia by DNA hypomethylation
29. Loss of Apc+ in intestinal adenomas from Min mice
30. β-Catenin mutations in cell lines established from human colorectal cancers
31. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer
32. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin
33. Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated β-catenin
34. 2-terminal truncated β-catenin on mouse intestinal epithelial homeostasis
35. Expression cloning of oncogenes by retroviral transfer of cDNA libraries
36. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression
37. T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant β-catenin
38. A method for the isolation and culture of human colonic crypts in collagen gels
39. Isolation of colonic crypts that maintain structural and metabolic viability in vitro
40. b-tsA58 transgenic mice
41. Derivation of conditionally immortalized cell lines containing the Min mutation from the normal colonic mucosa and other tissues of an "Immortomouse"/Min hybrid
42. Cell lines established by a temperature-sensitive simian virus 40 large T-antigen gene are growth restricted at the nonpermissive temperature
43. Deletion of an amino-terminal sequence β-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein
44. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
45. The metalloproteinase matrilysin (MMP-7) proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis
46. β-Catenin signaling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion
47. p19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
48. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
49. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
50. E1A signaling to p53 involves the p19(ARF) tumor suppressor
51. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis immortalization
52. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
53. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
54. Nucleolar Arf sequesters Mdm2 activates p53
55. INK4a/ARF mutations accelerate lymphomagenesis promote chemoresistance by disabling p53
56. Regulation of lef-mediated transcription p53-dependent pathway by associating β-catenin with CBP/p300
57. Exogenous expression of β-catenin regulates contact inhibition anchorage-independent growth anoikis radiation-induced cell cycle arrest
58. 1 cell cycle regulators
59. A genetic model for colorectal tumorigenesis
60. Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas
61. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro
62. Wild-type but not mutant APC associates with the microtubule cytoskeleton
63. APC binds to the novel protein EBI
64. Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein
65. Cloning and characterization of NE-dlg: A novel human homolog of the Drosophila discs large (dlg) tumor suppressor protein interacts with the APC protein
66. The adenomatous polyposis coli (APC) tumor suppressor
67. Phosphorylation of the tumor suppressor adenomatous polyposis coli (APC) by the cyclin-dependent kinase p34
68. RP1, a new member of the adenomatous polyposis coli-binding EB1-like gene family, is differentially expressed in activated T cells
69. Asef, a link between the tumor suppressor APC and G-protein signaling
70. Apoptosis and APC in colorectal tumorigenesis
71. 1 to S phase
72. The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration
73. The APC protein and E-cadherin form similar but independent complexes with α-catenin, β-catenin, and plakoglobin
74. Cellular oncogenes and multistep carcinogenesis